Patient Profile
- Maternal age:
- 32 years
- Height / Pre-preg weight:
- 164 cm / 78 kg (pre-pregnancy BMI 29.0 — overweight)
- Current weight:
- 87 kg (gain of 9 kg to date)
- Gestational age:
- 26 weeks 4 days, singleton
- Pregnancy:
- G3P1 — one prior macrosomic baby (4.2 kg)
- History:
- Family history of T2DM (mother). PCOS prior to conception. No prior GDM diagnosis. No corticosteroid use.
Summary Overview
Universal 75g 2-hour OGTT performed at 26+4 weeks (standard window). 3 timepoints analyzed; 2 of 3 values meet IADPSG / WHO 2013 thresholds for gestational diabetes mellitus (GDM). Diagnosis: Gestational Diabetes Mellitus.
Diagnostic Thresholds (IADPSG / WHO 2013)
- Fasting:
- ≥ 92 mg/dL (5.1 mmol/L)
- 1 hour:
- ≥ 180 mg/dL (10.0 mmol/L)
- 2 hour:
- ≥ 153 mg/dL (8.5 mmol/L)
- Diagnostic rule:
- One or more values meeting threshold = GDM [IADPSG, Diabetes Care 2010; WHO 2013]
Detailed Parameter Analysis
Risk Stratification
-
Gestational Diabetes Mellitus (GDM)Confirmed
Two values meet diagnostic thresholds. Pre-existing risk factors (BMI 29, PCOS, family T2DM, prior macrosomia) are concordant with the diagnosis [ADA Standards of Care 2025].
-
Pre-existing (overt) Type 2 DiabetesPossible — to evaluate
Fasting 98 is below the overt diabetes threshold (126 mg/dL), but HbA1c at this visit would help differentiate pre-existing from gestational pathology [ACOG Practice Bulletin 190, 2018].
Associated Maternal & Fetal Risks
Untreated or poorly controlled GDM is associated with increased rates of:
- Large-for-gestational-age (macrosomia) — birth weight > 90th percentile or > 4 kg
- Shoulder dystocia and birth trauma
- Cesarean delivery
- Neonatal hypoglycemia, jaundice, respiratory distress
- Preeclampsia and pregnancy-induced hypertension
- Long-term: maternal T2DM (~50% within 10 years), childhood obesity [Bellamy L, Lancet 2009]
Analytical Summary & Recommendations
Clinical pattern
GDM diagnosed at standard screening window. Risk profile is moderate: BMI 29, prior macrosomia, and family history of T2DM all add to baseline risk. The fasting elevation (most predictive of needing medication) suggests this presentation is more than mild.
Recommended next steps
- Refer to maternal diabetes/MFM team within 1 week for structured education
- Self-monitoring of blood glucose (SMBG) 4× daily — fasting and 1- or 2-hour post-prandial after each meal [ACOG 190, 2018]
- Medical nutrition therapy with a registered dietitian — carbohydrate distribution across meals/snacks, ~175 g/day minimum
- Moderate physical activity (e.g., walking 30 min after meals) unless contraindicated
- Glucose targets: fasting < 95 mg/dL, 1h post < 140 mg/dL, 2h post < 120 mg/dL [ADA 2025]
- Initiate insulin or metformin if >30% of values exceed targets after 1–2 weeks of lifestyle intervention
- Fetal growth ultrasound at 32–36 weeks (and serial as indicated)
- Antenatal surveillance per institutional protocol if pharmacotherapy is needed
- HbA1c at this visit — to differentiate from undiagnosed pre-existing T2DM
- Postpartum: 75g OGTT 6–12 weeks postpartum to screen for persistent diabetes [ACOG 190, 2018]
Key Questions for Your Physician
- Will I need insulin or oral medication, or can this be managed with diet and exercise alone?
- What home glucose targets should I aim for, and how often should I test?
- How will my baby be monitored as we approach delivery?
- What are the chances I'll develop type 2 diabetes after pregnancy, and what can I do to lower that risk?
- Is there a need to deliver earlier than 39–40 weeks?
What This Means for You
Your glucose tolerance test results show gestational diabetes (GDM) — your blood sugar rises higher than expected during pregnancy. This is common, manageable, and treatable; with good control, the great majority of pregnancies have excellent outcomes for mother and baby.
The most important next step is structured care: diabetes education, dietitian support, home glucose monitoring, and regular check-ins with your prenatal team. Most patients achieve target glucose levels with diet and modest exercise; some need insulin or metformin to reach those targets, which is a normal part of management — not a failure.
The aim is to keep your glucose in a tight range to reduce the chance of a large baby, birth complications, and postnatal blood-sugar problems for your baby. Your baby's growth will be checked by ultrasound in the third trimester.
After delivery, your blood sugar usually returns to normal, but you have an elevated long-term risk of type 2 diabetes — about 1 in 2 within 10 years. Follow-up testing 6–12 weeks postpartum, and lifestyle measures, are important parts of long-term care.
Diagnosis is straightforward against IADPSG/WHO criteria. Risk stratification benefits from confirmation that this is gestational rather than pre-existing diabetes — HbA1c and clinical context resolve the remaining uncertainty.
References
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33(3):676–82.
- HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. NEJM 2008;358(19):1991–2002.
- WHO. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. WHO 2013.
- ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstet Gynecol 2018;131(2):e49–e64.
- American Diabetes Association. Standards of Medical Care in Diabetes — 2025: Management of Diabetes in Pregnancy. Diabetes Care 2025;48(Suppl 1).
- Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet 2009;373:1773–9.